Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gaulard

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
Archives of Dermatology|April 29, 1998
Differences in Epstein-Barr virus expression between primary and secondary cutaneous angiocentric lymphomas. French Study Group of Cutaneous LymphomasJ Wechsler, R Willemze, A van der Brule, et al.
Anticancer Research|June 16, 1999
Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's diseaseP Kanavaros, M Vlychou, K Stefanaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomasE Campo, P Gaulard, E Zucca, et al.
Leukemia|October 26, 2002
Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristicsF Jardin, P Gaulard, G Buchonnet, et al.
Blood|June 1, 1990
Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma deltaJ P Farcet, P Gaulard, J P Marolleau, et al.
Oncogene|December 22, 2005
Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomasV Rouget-Quermalet, J Giustiniani, A Marie-Cardine, et al.
Blood|January 1, 1996
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)O Hermine, C Haioun, E Lepage, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphomaA Bosly, E Lepage, B Coiffier, et al.
The American Journal of Surgical Pathology|February 27, 2001
Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA studyD Cazals-Hatem, M André, N Mounier, et al.
Leukemia|August 22, 2003
Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomasE M Murga Penas, K Hinz, K Röser, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Archives of Dermatology|April 29, 1998
Differences in Epstein-Barr virus expression between primary and secondary cutaneous angiocentric lymphomas. French Study Group of Cutaneous LymphomasJ Wechsler, R Willemze, A van der Brule, et al.
Anticancer Research|June 16, 1999
Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's diseaseP Kanavaros, M Vlychou, K Stefanaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomasE Campo, P Gaulard, E Zucca, et al.
Leukemia|October 26, 2002
Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristicsF Jardin, P Gaulard, G Buchonnet, et al.
Blood|June 1, 1990
Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma deltaJ P Farcet, P Gaulard, J P Marolleau, et al.
Oncogene|December 22, 2005
Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomasV Rouget-Quermalet, J Giustiniani, A Marie-Cardine, et al.
Blood|January 1, 1996
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)O Hermine, C Haioun, E Lepage, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphomaA Bosly, E Lepage, B Coiffier, et al.
The American Journal of Surgical Pathology|February 27, 2001
Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA studyD Cazals-Hatem, M André, N Mounier, et al.
Leukemia|August 22, 2003
Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomasE M Murga Penas, K Hinz, K Röser, et al.
Pageof 18